Dendritic Cell Development and Maturation, Atherosclerosis, vol.417, pp.1-6, 1997. ,
The control of immunity and tolerance by dendritic cell, Pathol. Boil, vol.51, pp.59-60, 2003. ,
Human Dendritic Cell Functional Specialization in Steady-State and Inflammation, Front. Immunol, vol.5, 2014. ,
The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells, J. Exp. Med, vol.191, pp.411-416, 2000. ,
Altered dendritic cell functions in autoimmune diseases: Distinct and overlapping profiles, Nat. Rev. Rheumatol, vol.12, pp.703-715, 2016. ,
Dendritic cell therapy in cancer treatment; the state-of-the-art, Life Sci, vol.2020, 117580. ,
Dendritic cell subsets and locations, Int. Rev. Cell Mol. Biol, vol.348, pp.1-68, 2019. ,
Human dendritic cell subsets: An update, Immunology, vol.154, pp.3-20, 2018. ,
Langerhans cell origin and regulation, Curr. Opin. Hematol, vol.23, pp.28-35, 2016. ,
Inflammatory dendritic cells in mice and humans, Trends Immunol, vol.34, pp.440-445, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00846095
Monocyte-Derived Dendritic Cells Formed at the Infection Site Control the Induction of Protective T Helper 1 Responses against Leishmania. Immun, vol.26, pp.519-531, 2007. ,
Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells, Int. Rev. Immunol, vol.36, pp.57-73, 2017. ,
Role of Fc Receptors as a therapeutic target, Inflamm. Allergy Drug Targets, vol.8, pp.80-86, 2009. ,
Mouse and human FcR effector functions, Immunol. Rev, vol.268, pp.25-51, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01281740
The Role of TLR2 in Infection and Immunity. Front ,
Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance, J. Clin. Investig, vol.116, pp.916-928, 2006. ,
Toll-like receptors: Activation, signalling and transcriptional modulation, Cytokine, vol.74, pp.181-189, 2015. ,
C-type lectins in immunity and homeostasis, Nat. Rev. Immunol, vol.18, pp.374-389, 2018. ,
Self-and Nonself-Recognition by C-Type Lectins on Dendritic Cells, Annu. Rev. Immunol, vol.22, pp.33-54, 2004. ,
Dual function of C-type lectin-like receptors in the immune system, Curr. Opin. Cell Biol, vol.15, pp.539-546, 2003. ,
Signaling by myeloid C-type lectin receptors in immunity and homeostasis, Annu. Rev. Immunol, vol.30, pp.491-529, 2012. ,
Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-? production, Blood, vol.111, pp.4245-4253, 2008. ,
Fc? Receptor IIb Strongly Regulates Fc Receptor-Facilitated T Cell Activation by Dendritic Cells, J. Immunol, vol.189, pp.92-101, 2012. ,
The function of Fc? receptors in dendritic cells and macrophages, Nat. Rev. Immunol, vol.14, pp.94-108, 2014. ,
Fc RIIa Is Expressed on Natural IFN--Producing Cells (Plasmacytoid Dendritic Cells) and Is Required for the IFN-Production Induced by Apoptotic Cells Combined with Lupus IgG, J. Immunol, vol.171, pp.3296-3302, 2003. ,
Fc?RIII (CD16) equips immature 6-sulfo LacNAc-expressing dendritic cells (slanDCs) with a unique capacity to handle IgG-complexed antigens, BloodJ. Am. Soc. Hematol, vol.121, pp.3609-3618, 2013. ,
Anti-BDCA 2 monoclonal antibody inhibits plasmacytoid dendritic cell activation through Fc-dependent and Fc-independent mechanisms, Embo Mol. Med, vol.7, pp.464-476, 2015. ,
The Role of FcRn in Antigen Presentation, Front. Immunol, vol.5, 2014. ,
Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells, Proc. Natl. Acad. Sci, vol.108, pp.9927-9932, 2011. ,
The function of myeloid dendritic cells in rheumatoid arthritis, Rheumatol. Int, vol.37, pp.1043-1051, 2017. ,
Dendritic cells in the regulation of immunity and inflammation, Semin. Immunol, vol.35, pp.3-11, 2018. ,
Tolerogenic dendritic cells, Annu. Rev. Immunol, vol.21, pp.685-711, 2003. ,
Regulatory Dendritic Cells, Curr. Top. Microbiol. Immunol, vol.410, pp.47-71, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01438515
Ten Brinke, A. IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction-A comparative study of human clinical-applicable DC, Clin. Immunol, vol.142, pp.332-342, 2012. ,
, Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4 + CD25 + FOXP3 + Regulatory T-Cells. Diabetes, vol.57, pp.2341-2347, 2008.
Rapamycin Prolongs Graft Survival and Induces CD4+IFN-?+IL-10+ Regulatory Type 1 Cells in Old Recipient Mice, Transplantation, vol.102, pp.59-69, 2018. ,
Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation, Transpl. Int, vol.21, pp.483-494, 2008. ,
Adoptive Cell Therapy of Induced Regulatory T Cells Expanded by Tolerogenic Dendritic Cells on Murine Autoimmune Arthritis, J. Immunol. Res, pp.1-13, 2017. ,
Adoptive transfer of dendritic cells expressing CD11c reduces the immunological response associated with experimental colitis in BALB/c mice, PLoS ONE, vol.13, 2018. ,
, Mol. Med, vol.24, 2018.
Adoptive transfusion of tolerant dendritic cells prolong the survival of renal allografts: A systematic review, J. Evid. Based Med, vol.6, pp.250-264, 2013. ,
High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance, Transplantation, vol.85, pp.369-377, 2008. ,
Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells, Yonsei Med. J, vol.59, pp.807-815, 2018. ,
Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): A harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration, BMJ Open, vol.9, 2019. ,
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis, Ann. Rheum. Dis, vol.76, pp.227-234, 2016. ,
Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn's Disease: A Phase I Study, J. CrohnS Colitis, vol.9, pp.1071-1078, 2015. ,
The ONE Study compares cell therapy products in organ transplantation: Introduction to a review series on suppressive monocyte-derived cells, Transplant. Res, 2012. ,
Contact, Collaboration, and Conflict: Signal Integration of Syk-Coupled C-Type Lectin Receptors, J. Immunol, vol.198, pp.1403-1414, 2017. ,
Bendriss-Vermare, N. Cross Talk between Inhibitory Immunoreceptor Tyrosine-Based Activation Motif-Signaling and Toll-Like Receptor Pathways in Macrophages and Dendritic Cells, Front. Immunol, vol.8, 2017. ,
Signaling through Toll-like receptor 3 and Dectin-1 potentiates the capability of human monocyte-derived dendritic cells to promote T-helper 1 and T-helper 17 immune responses, Cytotherapy, vol.14, pp.598-607, 2012. ,
Dectin-1 Stimulation Induces Suppressor of Cytokine Signaling 1, Thereby Modulating TLR Signaling and T Cell Responses, J. Immunol, vol.188, pp.5644-5654, 2012. ,
Reciprocal regulation of IL-23 and IL-12 following co-activation of Dectin-1 and TLR signaling pathways, Eur. J. Immunol, vol.39, pp.1379-1386, 2009. ,
Interaction of Pattern Recognition Receptors with Mycobacterium Tuberculosis, J. Clin. Immunol, vol.35, pp.1-10, 2014. ,
C-type lectin receptors orchestrate antifungal immunity, Nat. Immunol, vol.13, pp.817-822, 2012. ,
Pattern recognition receptors in antifungal immunity, Semin. Immunopathol, vol.37, pp.97-106, 2014. ,
Pathogen recognition by DC-SIGN shapes adaptive immunity, Futur. Microbiol, vol.4, pp.879-890, 2009. ,
Faculty Opinions recommendation of Mycobacteria target DC-SIGN to suppress dendritic cell function, Fac. Opin. Post Publ. Peer Rev. Biomed. Lit, vol.197, pp.7-17, 2003. ,
DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production, J. Leukoc. Boil, vol.85, pp.518-525, 2008. ,
Fc?RI ?-Chain Negatively Modulates Dectin-1 Responses in Dendritic Cells, Front. Immunol, vol.8, 1424. ,
Fc?RIIa cross-talk with TLRs, IL-1R, and IFN?R selectively modulates cytokine production in human myeloid cells, Immunobiology, vol.220, pp.193-199, 2015. ,
Pathogen Strategies to Evade Innate Immune Response: A Signaling Point of View, pp.123-164, 2012. ,
DC-SIGN reacts with TLR-4 and regulates inflammatory cytokine expression via NF-?B activation in renal tubular epithelial cells during acute renal injury: DC-SIGN/TLR-4 regulates NF-?B activation, Clin. Exp. Immunol, vol.191, pp.107-115, 2018. ,
Mycobacterium tuberculosis impairs dendritic cell response by altering CD1b, DC-SIGN and MR profile, Immunol. Cell Boil, vol.88, pp.716-726, 2010. ,
Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2, J. Exp. Med, vol.197, pp.1107-1117, 2003. ,
TLR Cross-talk Confers Specificity to Innate Immunity, Int. Rev. Immunol, vol.33, pp.443-453, 2014. ,
Efficient Targeting of Protein Antigen to the Dendritic Cell Receptor DEC-205 in the Steady State Leads to Antigen Presentation on Major Histocompatibility Complex Class I Products and Peripheral CD8+ T Cell Tolerance, J. Exp. Med, vol.196, pp.1627-1638, 2002. ,
CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells1, J. Immunol, vol.181, pp.6923-6933, 2008. ,
Cutting edge: Langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo, J. Immunol, vol.180, pp.3647-3650, 2008. ,
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies ,
URL : https://hal.archives-ouvertes.fr/hal-01438144
Bispecific antibodies: The next generation of targeted inflammatory bowel disease therapies, Autoimmun. Rev, vol.18, pp.123-128, 2019. ,
New structural formats of therapeutic antibodies for rheumatology, Jt. Bone Spine, vol.85, pp.47-52, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02414904
Alternative molecular formats and therapeutic applications for bispecific antibodies, Mol. Immunol, vol.67, pp.95-106, 2015. ,
, Drug Discov. Today, vol.20, pp.838-847, 2015.
Antibodies to watch in 2020, vol.12, pp.183-203, 2019. ,
Novel biologics targeting the P2X7 ion channel, Curr. Opin. Pharmacol, vol.47, pp.110-118, 2019. ,
A bispecific antibody strategy to target multiple type 2 cytokines in asthma, J. Allergy Clin. Immunol, vol.142, pp.1185-1193, 2018. ,
Bispecific Antibodies and Trispecific Immunocytokines for Targeting the Immune System Against Cancer: Preparing for the Future, BioDrugs, vol.27, pp.35-53, 2013. ,
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques, vol.358, pp.85-90, 2017. ,
Generation of orthogonal Fab-based trispecific antibody formats, Protein Eng. Des. Sel, vol.31, pp.249-256, 2018. ,
Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells, Protein Eng. Des. Sel, vol.30, pp.673-684, 2017. ,
Building blocks for bispecific and trispecific antibodies, Methods, vol.154, pp.3-9, 2019. ,
Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity, Nat. Commun, vol.9, pp.1-12, 2018. ,